CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Clinical trials for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a gentle pill stop blood cancer before it starts?
Disease control Not yet recruitingThis study tests a low-dose oral drug (decitabine with tetrahydrouridine) in 80 adults aged 60–85 who have a high-risk blood condition called CCUS, which often leads to blood cancer. The drug aims to reduce harmful mutations in blood cells and restore normal blood production with…
Matched conditions: CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Not yet recruitingThis study is a registry that will collect medical information and blood samples from 500 adults with myelodysplastic syndromes (MDS) and related conditions. The goal is to learn more about how these diseases develop and progress over time. Participants will not receive any exper…
Matched conditions: CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC